UBS Maintains a 'Buy' on Watson Pharmaceuticals (WPI); Bullish on Acquisition Announcement
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Watson Pharmaceuticals (NYSE: WPI) price target raised from $71 to $80.
Analyst, Marc Goodman, said, "The pros of the deal include diversification, synergies, lower tax rate, capabilities in injectables, semi-solids, liquids, and biosimilars (insulin), low cost manuf. and CRO, and 3rd party EU dossier dev. The Actavis biz. is better than we thought. It appears $8.00 is the base case and, while we are only taking our estimate there for 2013, we could see it move north of $8.25. For 2014 we had pointed to $8.66. Now we are moving to $9.00, but we wouldn’t be surprised if 2012 end up > $9.50."
For an analyst ratings summary and ratings history on Watson Pharmaceuticals click here. For more ratings news on Watson Pharmaceuticals click here.
Shares of Watson Pharmaceuticals closed at $69.69 yesterday.
Analyst, Marc Goodman, said, "The pros of the deal include diversification, synergies, lower tax rate, capabilities in injectables, semi-solids, liquids, and biosimilars (insulin), low cost manuf. and CRO, and 3rd party EU dossier dev. The Actavis biz. is better than we thought. It appears $8.00 is the base case and, while we are only taking our estimate there for 2013, we could see it move north of $8.25. For 2014 we had pointed to $8.66. Now we are moving to $9.00, but we wouldn’t be surprised if 2012 end up > $9.50."
For an analyst ratings summary and ratings history on Watson Pharmaceuticals click here. For more ratings news on Watson Pharmaceuticals click here.
Shares of Watson Pharmaceuticals closed at $69.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
